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Background: The determinants of sex differences in prevalence and mortality of congenital heart disease (CHD) patients are poorly understood. 
Our aim was two-fold: 1) to describe sex differences in hospital mortality of adult CHD patients, and 2) to determine the impact of the care 
associated with reproductive health on hospital mortality of females with CHD.
Methods: We used the Quebec CHD database and the Dutch CONCOR registry to capture a wide sample of adult CHD patients with comprehensive 
health services records in two countries. We included CHD patients aged 18 to 65 who had any hospitalization between 1996-2005. Poisson 
regression was used to analyze 30-day in-hospital mortality in females vs. males and in females age 18-45 with and without a pregnancy history, 
after adjustment for CHD severity, co-morbidities and admission diagnosis.
Results: Of 39,776 patients followed for 259,741 patient years, 19,099 patients (48%) were hospitalized. Of 54,195 admissions, 62% were in 
females, of which 28% were for pregnancy-related diagnoses. Cardiovascular admissions accounted for 32% and 44% of non-pregnancy admissions 
in females and males respectively. In those 18-45 years of age and admitted for non-pregnancy-related diagnoses, the adjusted rate ratio (RR) for 
30-day in-hospital mortality was 0.74 (95% confidence interval (CI) 0.55-0.98) in females compared to males. In females with a pregnancy history 
compared to those without, the adjusted RR for 30-day in-hospital mortality was 0.49 (95% CI 0.24-0.99) among non-pregnancy admissions. While 
pregnancy resulted in more pregnancy-related health services utilization (HSU), it did not translate to increased cardiac HSU.
Conclusions: For CHD patients aged 18-45, 30-day in-hospital mortality for non-pregnancy admissions was lower in females than in males, and 
lower in females with a pregnancy history than those without, although the latter did not correlate with a more intense cardiac follow-up. Our study 
suggests that reproductive surveillance is not the main mechanism by which females with a pregnancy history had lower in-hospital mortality. 
Studies are needed to explore the impact of primary biological pathways on outcomes in CHD patients.
